{"doi":"10.1016/j.ebiom.2024.105103","title":"Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses","abstract":null,"journal":"eBioMedicine","year":2024,"id":638716,"datarank":0.40620753016533157,"base_score":2.70805020110221,"endowment":2.70805020110221,"self_citation_contribution":0.40620753016533157,"citation_network_contribution":0.0,"self_endowment_contribution":0.40620753016533157,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":14,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1299738,"name":"Peter Jester","orcid":"0000-0003-2802-7451","position":1,"is_corresponding":false},{"id":1133284,"name":"Chunyang Gu","orcid":"0000-0003-1283-1701","position":2,"is_corresponding":false},{"id":1124832,"name":"Lizheng Guan","orcid":null,"position":3,"is_corresponding":false},{"id":640879,"name":"Tammy Armbrust","orcid":"0000-0002-0997-2434","position":4,"is_corresponding":false},{"id":335129,"name":"Joshua G. Petrie","orcid":"0000-0002-5696-965X","position":5,"is_corresponding":false},{"id":268705,"name":"Jennifer P. King","orcid":"0000-0003-4627-1378","position":6,"is_corresponding":false},{"id":337493,"name":"Huong Q. Nguyen","orcid":"0000-0002-3650-3705","position":7,"is_corresponding":false},{"id":105912,"name":"Edward A. Belongia","orcid":"0000-0001-7478-0415","position":8,"is_corresponding":false},{"id":107104,"name":"Peter Halfmann","orcid":"0000-0002-1648-1625","position":9,"is_corresponding":false},{"id":325374,"name":"Gabriele Neumann","orcid":"0000-0001-7054-1775","position":10,"is_corresponding":false},{"id":107110,"name":"Yoshihiro Kawaoka","orcid":"0000-0001-5061-8296","position":11,"is_corresponding":false},{"id":456513,"name":"David Pattinson","orcid":"0000-0003-0001-8203","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses","abstract":"BACKGROUND: World Health Organisation (WHO) and USA Centers for Disease Control and Prevention (U.S. CDC) recommendations now allow simultaneous administration of COVID-19 and other vaccines. We compared antibody responses after coadministration of influenza and bivalent COVID-19 vaccines in the same (ipsilateral) arm vs. different (contralateral) arms. METHODS: Pre- and post-vaccination serum samples from individuals in the Prospective Assessment of COVID-19 in a Community (PACC) cohort were used to conduct haemaglutination inhibition (HI) assays with the viruses in the 2022-2023 seasonal influenza vaccine and focus reduction neutralisation tests (FRNT) using a BA.5 SARS-CoV-2 virus. The effect of ipsilateral vs. contralateral vaccination on immune responses was inferred in a model that accounted for higher variance in vaccine responses at lower pre-vaccination titers. FINDINGS: Ipsilateral vaccination did not cause higher influenza vaccine responses compared to contralateral vaccination. The response to SARS-CoV-2 was slightly increased in the ipsilateral group, but equivalence was not excluded. INTERPRETATION: Coadministration of influenza and bivalent COVID-19 vaccines in the same arm or different arms did not strongly influence the antibody response to either vaccine. FUNDING: This work was supported by the U.S. CDC (grant number: 75D30120C09259).","is_dataset_classified":null,"base_score":2.70805020110221,"endowment":2.70805020110221,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"38574407","pmcid":"PMC11004685","openalex_id":"https://openalex.org/W4393867421","authors":[],"funders":[{"funder_name":"CDC","grant_id":"","title":null}],"total_grants":1,"fwci":4.2174,"citation_percentile":0.95080373,"influential_citations":0,"citation_trend":[{"year":2024,"count":3},{"year":2025,"count":11}],"oa_status":"gold","license":"cc-by-nc","oa_locations":[{"url":"http://www.thelancet.com/article/S2352396424001385/pdf","host_type":"journal"},{"url":"http://www.thelancet.com/article/S2352396424001385/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S2352396424001385?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S2352396424001385?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.ebiom.2024.105103","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/38574407","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11004685","host_type":"repository"},{"url":"https://doaj.org/article/910987c78da44f6ba76b3c55d9dc439d","host_type":"repository"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11004685/pdf/main.pdf","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC11004685","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC11004685?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["SARS-CoV-2 and COVID-19 Research","Influenza Virus Research Studies","Respiratory viral infections research","Humans","Influenza Vaccines","Antibodies, Viral","COVID-19 Vaccines","COVID-19","SARS-CoV-2","Male","Female","Middle Aged","Influenza, Human","Adult","Antibody Formation","Vaccination","Aged","Prospective Studies","Antibodies, Neutralizing"],"mesh_terms":["COVID-19","SARS-CoV-2","COVID-19 Vaccines","Adult","Aged","Antibodies, Viral","Antibody Formation","Female","Humans","Influenza, Human","Influenza Vaccines","Male","Middle Aged","Prospective Studies","Vaccination","Antibodies, Neutralizing"],"keywords":["Vaccination","Medicine","Immunology","Antibody","Influenza vaccine","Bivalent (engine)","Virology","Coronavirus disease 2019 (COVID-19)","Titer","Antibody response","Vaccine efficacy","Antibody titer","Immune system","Trivalent influenza vaccine","Neutralizing antibody","Cohort","Infectious disease (medical specialty)","Disease","Internal medicine","Influenza","Contralateral","Ipsilateral","Coadministration","Covid-19","Sars-cov-2"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-06T21:16:33.444451Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}